Glucan In Treatment Of Low-density Lipoprotein (ldl) Cholesterol
- By Betül Gürünlü1
-
View Affiliations Hide AffiliationsAffiliations: 1 "Üsküdar Üniversitesi,Biyomühendislik Bölümü,Merkez Yerleşke A Blok 325/AAltunizade, Üsküdar, İstanbul, Turkey"
- Source: Medical Applications of Beta-Glucan , pp 53-62
- Publication Date: January 2022
- Language: English
Hypercholesterolemia is one of the most important risk elements of cardiovascular disease causing metabolic syndrome, diabetes, hypertension. Although there is a development in this subject, the studies for finding new ways of preventing and healing dyslipidemia are continuing, and current treatments for cardiovascular diseases are stimulating different side effects. There are two kinds of β-glucans, insoluble and soluble. These supplements directly interact with biliary salts and lipids and in the bowel and decrease the level of cholesterol [1]. The patients having dyslipidemia can be healed by using the therapeutic effect of β-glucans as they do not create any significant side effects. In this review, the healing effect of β-glucans on decreasing cholesterol levels in humans.
-
From This Site
/content/books/9789815039238.chap6dcterms_subject,pub_keyword-contentType:Journal105